Methylene blue associated with maghemite nanoparticles has antitumor activity in breast and ovarian carcinoma cell lines
Abstract Background Cancer constitutes group of diseases responsible for the second largest cause of global death, and it is currently considered one of the main public health concerns nowadays. Early diagnosis associated with the best choice of therapeutic strategy, is essential to achieve success...
Main Authors: | Ana Luísa G. Silva, Natália V. Carvalho, Leonardo G. Paterno, Ludmilla D. Moura, Cleber L. Filomeno, Eneida de Paula, Sônia N. Báo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Cancer Nanotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12645-021-00083-x |
Similar Items
-
Screening the products of Streptomyces using cell culture technique to detect antitumor agents
by: Saeed tajbakhsh, et al.
Published: (2009-02-01) -
Genkwanin nanosuspensions: a novel and potential antitumor drug in breast carcinoma therapy
by: Yijing Li, et al.
Published: (2017-01-01) -
Toxicity and Antitumor Activity of a Thiophene–Acridine Hybrid
by: Thaís Lisboa, et al.
Published: (2019-12-01) -
The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor
by: Qian Yu, et al.
Published: (2019-01-01) -
Microgramma vacciniifolia frond lectin (MvFL) exhibits antitumor activity against sarcoma 180 in mice
by: Leydianne Leite de Siqueira Patriota, et al.
Published: (2021-02-01)